Lecture

Tumor Immunology: Immune Responses and Cancer Therapy

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

In course

BIO-479: Immunology - advances and therapeutic implications

The students acquire advanced level knowledge regarding the functioning of the (vertebrate) immune system. A strong focus is placed on the molecular mechanisms underlying innate and adaptive immune responses and their implications for medicine. ...

Description

This lecture explores the immune responses to tumors, focusing on tumor antigens, oncogenic viruses, and overexpressed genes. It delves into the mechanisms of cancer immunity, regulatory immunity, and the role of inflammation in tumorigenesis. The instructor discusses the use of immune checkpoint therapy, adoptive T cell transfer therapy, and cancer vaccines in cancer treatment, highlighting the challenges and potential of personalized cancer vaccines and combination therapies.

This video is available exclusively on Mediaspace for a restricted audience. Please log in to MediaSpace to access it if you have the necessary permissions.

Watch on Mediaspace

Official source

Ontological neighbourhood

Health sciences

Immunology: Immune system

Biology

Cell biology: Cancer

Related concepts (32)

Immunotherapy

Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies. Immunotherapy is under preliminary research for its potential to treat various forms of cancer. Cell-based immunotherapies are effective for some cancers.

Tumor-infiltrating lymphocytes

Tumor-infiltrating lymphocytes (TIL) are white blood cells that have left the bloodstream and migrated towards a tumor. They include T cells and B cells and are part of the larger category of ‘tumor-infiltrating immune cells’ which consist of both mononuclear and polymorphonuclear immune cells, (i.e., T cells, B cells, natural killer cells, macrophages, neutrophils, dendritic cells, mast cells, eosinophils, basophils, etc.) in variable proportions. Their abundance varies with tumor type and stage and in some cases relates to disease prognosis.

Adoptive cell transfer

Adoptive cell transfer (ACT) is the transfer of cells into a patient. The cells may have originated from the patient or from another individual. The cells are most commonly derived from the immune system with the goal of improving immune functionality and characteristics. In autologous cancer immunotherapy, T cells are extracted from the patient, genetically modified and cultured in vitro and returned to the same patient. Comparatively, allogeneic therapies involve cells isolated and expanded from a donor separate from the patient receiving the cells.

Antigen

In immunology, an antigen (Ag) is a molecule, moiety, foreign particulate matter, or an allergen, such as pollen, that can bind to a specific antibody or T-cell receptor. The presence of antigens in the body may trigger an immune response. Antigens can be proteins, peptides (amino acid chains), polysaccharides (chains of simple sugars), lipids, or nucleic acids. Antigens exist on normal cells, cancer cells, parasites, viruses, fungi, and bacteria. Antigens are recognized by antigen receptors, including antibodies and T-cell receptors.

Cancer immunology

Cancer immunology is an interdisciplinary branch of biology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well known application is cancer immunotherapy, which utilises the immune system as a treatment for cancer. Cancer immunosurveillance and immunoediting are based on protection against development of tumors in animal systems and (ii) identification of targets for immune recognition of human cancer.

Related lectures (64)

Immune Engineering: Cancer Immunotherapy Strategies

Explores cancer immunotherapy strategies, including blocking inhibitory pathways, increasing effector T cells, and enhancing cancer vaccines.

Material Engineering in Cancer Immunotherapy

Covers the evasion of immune pressure by tumors, cancer immunotherapies, drug delivery strategies, and the impact of nanoparticle characteristics on tumor penetration.

Experimental Evidence for Immunoediting of Tumors

Explores experimental evidence supporting immunoediting of tumors and the use of immunotherapy to enhance antitumor immune responses.

Cancer Immunotherapies: History, Players, and Mechanisms

Explores the history, mechanisms, and players of cancer immunotherapies, including immune evasion strategies and the role of MHC in antigen presentation.

Adaptive Immune Response: Steps and Activation MOOC: Introduction to immunology (part 1)